Matthias Schwebe

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Matthias Schwebe is an author at Universitätsmedizin Greifswald specializing in pharmacology, cardiovascular pharmacodynamics, and cardiovascular disease.

Publications per year

2011–2017

Publications

Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy

Matthias Schwebe, Sabine Ameling, Elke Hammer et al. · Biochemical Pharmacology · 2015 · 33 citations

Medicine, Cardiology, Pharmacology +17

Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells

Sabine Ameling, Elke Hammer, Sebastian Herzog et al. · Molecular Pharmacology · 2012 · 24 citations

Life Sciences, Immunology, Oncology +17

Acute Exposure to Doxorubicin Results in Increased Cardiac P-glycoprotein Expression

Thomas Budde, Jeanette Haney, Sandra Bien et al. · Journal of Pharmaceutical Sciences · 2011 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +16

Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transporters

Judith V. Monzel, Thomas Budde, Henriette E. Meyer zu Schwabedissen et al. · Biochemical Pharmacology · 2017 · 15 citations

Medicine, Biochemistry, Pharmacology +16

1–4 of 4